📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road. (2015)

First Author: Caunt CJ

Attributed to: To define the molecular mechanisms that determine cellular and organismal longevity funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nrc4000

PubMed Identifier: 26399658

Publication URI: http://europepmc.org/abstract/MED/26399658

Type: Journal Article/Review

Volume: 15

Parent Publication: Nature reviews. Cancer

Issue: 10

ISSN: 1474-175X